What do NAFDAC, NMPA, FDA clinical trials, international registrations, and decades of scientific research tell us about Tasly? More importantly, what does it mean for consumers seeking evidence-based herbal healthcare?
Based on the information displayed in your images and verified through official and industry sources, the story of Tasly is not merely about selling health products. It is about attempting something few Traditional Chinese Medicine (TCM) companies have successfully pursued: bringing herbal medicine through the same rigorous scientific pathways demanded by modern pharmaceutical regulators.
The Challenge Facing Herbal Medicine Worldwide
For decades, herbal medicine faced one major criticism:
"Where is the clinical evidence?"
Many herbal products around the world are marketed as supplements and therefore never undergo the costly and lengthy process required for pharmaceutical approval.
The chart shown in your image highlights a reality that every pharmaceutical company understands:
- Drug development commonly takes 10–15 years
- Development costs often exceed $1.5–2.6 billion
- Failure rates can exceed 85–90%
These are not obstacles many herbal medicine manufacturers are willing to face.
Tasly chose a different route.
Who is Tasly?
was founded in 1994 and has grown into one of China's most recognized pharmaceutical and health technology enterprises.
According to the company's published profile, Tasly has:
- Undertaken numerous national drug-development projects
- Received multiple national scientific awards
- Built one of the world's most advanced intelligent manufacturing systems for herbal medicines
- Expanded registration of its products across dozens of countries and regions worldwide.
From Ancient Herbs to Modern Clinical Trials
One of Tasly's greatest achievements has been transforming traditional herbal formulations into products that can withstand modern pharmaceutical scrutiny.
The company developed the well-known Dantonic® (Compound Danshen Dripping Pill/T89) for cardiovascular health.
What makes this important?
Tasly became one of the first Chinese medicine companies to move a traditional herbal formulation through the U.S. FDA clinical trial process.
The company's historical records indicate:
- FDA IND approval was obtained for Dantonic
- Phase II clinical trials were completed in the United States
- Large international Phase III studies were subsequently conducted
- Multi-center studies involved numerous hospitals and research institutions across North America and Europe.
This is a milestone that very few herbal medicine companies worldwide have achieved.
Understanding FDA, NMPA and NAFDAC
NMPA (China)
The National Medical Products Administration regulates medicines within China.
Before a medicine reaches international markets, it must first satisfy regulatory standards within China's pharmaceutical system.
Tasly products have undergone this pathway and continue to participate in clinical development programs regulated by NMPA.
FDA (United States)
The U.S. Food and Drug Administration is regarded as one of the world's most demanding regulatory agencies.
FDA involvement does not automatically mean a product is fully FDA-approved for marketing as a drug.
However, when a product enters FDA-regulated clinical trials, it means:
- Manufacturing standards are scrutinized
- Safety data are reviewed
- Clinical protocols are evaluated
- Efficacy must be demonstrated scientifically
Tasly's Dantonic/T89 program reached FDA-regulated Phase III development, a rare achievement for a traditional Chinese botanical medicine.
NAFDAC (Nigeria)
The National Agency for Food and Drug Administration and Control regulates products sold in Nigeria.
For products legally marketed in Nigeria, NAFDAC registration confirms that the products have passed local regulatory requirements regarding importation, labeling, safety review, and distribution standards.
Consumers should always verify current NAFDAC registration numbers independently through official NAFDAC channels before purchase.
What Makes Tasly Different?
1. Scientific Validation
Many herbal products rely solely on traditional usage.
Tasly invested heavily in:
- Clinical trials
- Pharmacological research
- Quality control systems
- Standardized manufacturing
According to company publications, over a thousand clinical research projects have contributed to its product development programs.
2. Pharmaceutical Manufacturing Standards
Tasly reports operating one of the world's largest automated dripping-pill production systems.
This technology was designed to ensure:
- Consistent dosage
- Batch-to-batch uniformity
- Reduced contamination risks
- Higher manufacturing precision
Such consistency is essential when attempting international registration.
3. Global Expansion
Tasly reports obtaining hundreds of registrations and certifications across more than 50 countries and regions.
Its flagship cardiovascular products have been registered through multiple regulatory pathways internationally.
Products Highlighted in Your Images
Kasly Female Capsule
The display describes support for:
- Female reproductive health
- Fibroid-related concerns
- Menstrual discomfort
- Postpartum recovery support
These claims should be understood within the context of local regulatory approvals and traditional-use evidence. Consumers should consult qualified healthcare professionals regarding diagnosis and treatment of medical conditions.
Kasly Qingwen Capsule
The display promotes support for:
- Respiratory health
- Cold and flu symptoms
- Immune support
- Recovery from viral illnesses
Traditional Chinese formulations similar to Qingwen-type products became internationally recognized during respiratory disease outbreaks, leading to increased scientific investigation into their mechanisms and effectiveness.
ICP Capsule
The image describes support for:
- Cardiovascular health
- Blood circulation
- Microcirculation improvement
- Heart and vascular protection
Published product information associates ICP Capsule with ingredients such as Danshen and Notoginseng, herbs long studied for cardiovascular applications.
Why This Matters to Consumers
The modern healthcare consumer faces a difficult challenge:
How do you distinguish between:
- A traditional remedy with little scientific validation?
- A health supplement with minimal testing?
- A product backed by clinical research and pharmaceutical development?
Tasly's significance lies in its effort to bridge these worlds.
Rather than abandoning traditional Chinese medicine, the company attempted to subject herbal formulations to:
- Laboratory research
- Clinical trials
- Regulatory review
- International manufacturing standards
This does not mean every product is FDA-approved as a prescription drug. It does mean that portions of the company's portfolio have undergone levels of scientific investigation rarely seen in the herbal medicine sector.
Final Thoughts
For more than three decades, Tasly has pursued a vision that many considered impossible: proving that traditional herbal medicine can be evaluated using the same scientific principles applied to modern pharmaceuticals.
The images you shared tell a story larger than product marketing. They reflect a long-term commitment to:
- Pharmaceutical-quality manufacturing
- International clinical research
- Regulatory engagement with agencies such as NMPA, FDA, and national authorities around the world
- Global acceptance of evidence-based Traditional Chinese Medicine
Whether one approaches Tasly from the perspective of herbal medicine, cardiovascular health, immune support, or pharmaceutical innovation, its journey represents one of the most ambitious efforts ever made to bring Traditional Chinese Medicine into the mainstream of global healthcare.
